Immunoclin (Immunoclin) Additional Paid-In Capital : $42.89 Mil(As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Additional Paid-In Capital?

Immunoclin's quarterly additional paid-in capital increased from Apr. 2014 ($33.21 Mil) to Jul. 2014 ($33.49 Mil) and increased from Jul. 2014 ($33.49 Mil) to Oct. 2014 ($42.89 Mil).

Immunoclin's annual additional paid-in capital increased from Feb. 2012 ($0.01 Mil) to Jan. 2013 ($0.07 Mil) and increased from Jan. 2013 ($0.07 Mil) to Jan. 2014 ($33.16 Mil).

Immunoclin Additional Paid-In Capital Historical Data

The historical data trend for Immunoclin's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Additional Paid-In Capital Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Additional Paid-In Capital

0.01

0.07

33.16

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Additional Paid-In Capital	Get a 7-Day Free Trial									0.72	0.72	33.21	33.49	42.89

Immunoclin Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Immunoclin Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Immunoclin's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines